Royal Bank of Canada’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-53,800
Closed -$1.31M 6644
2019
Q2
$1.31M Sell
53,800
-120,000
-69% -$2.47M ﹤0.01% 3094
2019
Q1
$2.25M Buy
173,800
+53,800
+45% +$942K ﹤0.01% 2590
2018
Q4
$1.81M Sell
120,000
-120,000
-50% -$3.1M ﹤0.01% 2729
2018
Q3
$9.43M Buy
240,000
+120,000
+100% +$5.41M ﹤0.01% 1656
2018
Q2
$5.9M Buy
+120,000
New +$6.81M ﹤0.01% 1903
2017
Q4
Sell
-50,000
Closed -$4.2M 6493
2017
Q3
$4.2M Hold
50,000
﹤0.01% 2108
2017
Q2
$3.27M Buy
+50,000
New +$3.4M ﹤0.01% 2231

Other funds holding ADNT

Royal Bank of Canada's ADNT Position: Q1 2026 in Review

Royal Bank of Canada reduced its Adient (ADNT) stake by 53% in Q1 2026, selling an estimated $75.3K and leaving 3,045 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #5384.

Royal Bank of Canada first reported a position in ADNT in Q4 2016 and has held it in 38 quarters since. The position peaked at $17.6M in Q3 2025. 287 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

  • Royal Bank of Canada held 3,045 shares of Adient worth $61K as of Q1 2026.
  • Royal Bank of Canada sold 3,387 Adient shares in Q1 2026, an estimated $75.3K.
  • Adient made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5384 holding.
  • Royal Bank of Canada first reported a position in Adient in Q4 2016 and has held it in 38 quarters since.
  • Royal Bank of Canada's Adient position peaked at $17.6M in Q3 2025.
  • 287 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.